NCT04688736View on ClinicalTrials.gov

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

PHASE2RecruitingINTERVENTIONAL
Enrollment

6,642

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Allergic Transfusion Reaction
Interventions
DRUG

Placebo

The tablet resembles chlorpheniramine but has no therapeutic value.

DRUG

Chlorpheniramine

An antihistamine that reduces the natural chemical histamine in the body.

Trial Locations (4)

Unknown

NOT_YET_RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

Zhoukou Central Hospital, Zhoukou

RECRUITING

The Second Affilated Hospital of Shandong First Medical University, Tai’an

RECRUITING

Regenerative Medicine Center, Tianjin

All Listed Sponsors
lead

Institute of Hematology & Blood Diseases Hospital, China

OTHER